Skip to main content
HRES 26 107th Congress House Health Canada Commerce Drug industry Drugs Latin America Mexico Prescription pricing Price policy

Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.

Introduced: January 31, 2001 See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 107th Congress
It was not agreed to before the 107th Congress (2001–2002) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Agreed to (House)
Feb 14, 2001
Referred to the Subcommittee on Health.
Feb 1, 2001
Sponsor introductory remarks on measure. (CR E98)
Jan 31, 2001
Introduced in House
Jan 31, 2001
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Expresses the sense of the House of Representatives that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.
What's happening now February 14, 2001

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
McGovern, James P.
Massachusetts · Mar 7, 2001
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 26: Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.. 107th Congress. Open America. https://openamerica.io/bill/107-HRES-26/
MLA
"H. Res. 26: Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HRES-26/.
Bluebook (legal)
H. Res. 26, 107th Cong. (2026), https://openamerica.io/bill/107-HRES-26/.
Markdown link
[H. Res. 26: Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.](https://openamerica.io/bill/107-HRES-26/)
Report a problem